Gilead Sciences, Inc. SEC filings GILD

Gilead Sciences, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Apr 4, 2018. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Mar 20, 2026 Dec 31, 2025
10-K Annual report Feb 24, 2026 Dec 31, 2025
ARS Annual report to shareholders Mar 27, 2025 Dec 31, 2024
10-K Annual report Feb 28, 2025 Dec 31, 2024
ARS Annual report to shareholders Mar 28, 2024 Dec 31, 2023
10-K Annual report Feb 23, 2024 Dec 31, 2023
10-K Annual report Feb 22, 2023 Dec 31, 2022
10-K Annual report Feb 23, 2022 Dec 31, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
10-K Annual report Feb 25, 2020 Dec 31, 2019
10-K/A Amended annual report Apr 18, 2019 Dec 31, 2018
10-K Annual report Feb 26, 2019 Dec 31, 2018

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
GILD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Foster City, CA
SEC filer status
Large accelerated filer
SEC CIK
882095
Former names
GILEAD SCIENCES INC (until Feb 17, 2022)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.